Shengtai Pharmaceutical, Inc. Reports Unaudited Third Quarter Fiscal 2009 Financi...(Net (loss) income ...),Health

Date:5/15/2009

Net (loss) income $ (505,489) $ 7,269,249 Adjustments to reconcile net income to cash provided by operating activities: Depreciation 3,612,903 2,076,992 Amortization 40,225 38,263 Allowance for bad debts 50,387 16,558 Stock based employee compensation 476,454 158,818 Loss (Gain) on equipment disposal 159,269 (91,480) Gain on disposal of land use right -- (24,783) Earnings on equity investment (92,936) (192,826) Amortization of discount on capital lease obligation 146,681 -- Change in operating assets and liabilities: Accounts receivable 1,076,312 (1,108,695) Notes receivable 310,963 380,411 Other receivables 444,622 1,987,660 Inventories (1,869,045) (1,404,996) Prepayments (471,355) (620,451) Accounts payable (1,614,791) (595,474) Accounts payable - related party (79,896) (1,252,106) Accrued liabilities (49,430) (568,922) Accrued liabilities - related party -- 482,160 Other payable 596,396 362,035 Customer deposit 921,757 297,543 Taxes payable (2,031,181) 2,261,984 Net cash provided by operating activities 1,121,846 9,471
'/>"/>

SOURCE Shengtai Pharmaceutical, Inc. Copyright©2009 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12
Related medicine news :

1. Shengtai Pharmaceutical Schedules 2009 Third Quarter Financial Results and Conference Call
2. Shengtai Pharmaceutical Hosts Key Customers at Its Headquarters for Facility Tour and Technology Exchange Conference
3. Shengtai Pharmaceutical, Inc. Comments On Its Operations
4. Shengtai Pharmaceutical Schedules 2009 Second Quarter Financial Results and Conference Call
5. Shengtai Pharmaceutical, Inc. Comments on Chinas Recently Approved Health Care Reform Plan
6. Shengtai Pharmaceutical to Present at Roth 21st Annual OC Growth Stock Conference
7. Shengtai Pharmaceutical Expands International Sales Program
8. Shengtai Pharmaceutical, Inc. Reports Third Quarter Results of Fiscal Year 2008
9. Shengtai Pharmaceutical, Inc. Announces Conference Call to Discuss Third Quarter Results of Fiscal Year 2008
10. Shengtai Pharmaceutical, Inc. Reports Strong Second Quarter Results of Fiscal Year 2008
11. Shengtai Pharmaceutical, Inc. to Present at Roth Conference